PTEN and Familial prostate cancer: Positive: expansion of immunosuppressive (iNOS, arginase) CD11b+Gr1+ MDSC in prostate immediately following Pten deletion in a murine prostate cancer model. This was particularly apparent at invasive carcinoma stage and was likely due to upregulation of epithelial cell-derived CSF1 and IL1β.